Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genedx Holdings Corp 333 Ludlow Street North Tower 6th Floor Stamford CT 06902 USA

www.genedx.com Employees: 1,000 P: 888-729-1206

Description:

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

Key Statistics

Overview:

Market Capitalization, $K 1,905,938
Enterprise Value, $K 1,858,948
Shares Outstanding, K 27,471
Annual Sales, $ 202,570 K
Annual Net Income, $ -175,770 K
Last Quarter Sales, $ 76,870 K
Last Quarter Net Income, $ -8,310 K
EBIT, $ -57,660 K
EBITDA, $ -23,930 K
60-Month Beta 2.11
% of Insider Shareholders 27.30%
% of Institutional Shareholders 61.72%
Float, K 19,971
% Float 72.70%
Short Volume Ratio 0.41

Growth:

1-Year Return 5,184.29%
3-Year Return -69.49%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 10/29/24
Next Earnings Date N/A
Earnings Per Share ttm -0.99
EPS Growth vs. Prev Qtr 136.36%
EPS Growth vs. Prev Year 104.88%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-33 on 05/04/23

WGS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -13.35%
Return-on-Assets % -6.91%
Profit Margin % -86.77%
Debt/Equity 0.25
Price/Sales 9.63
Price/Cash Flow N/A
Price/Book 9.54
Book Value/Share 7.44
Interest Coverage -0.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar